Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience - Pokorny, T; Preller, K H; Kraehenmann, R (Eur Neuropsychopharmacology, 2016)
et al.